According to estimates more than 400 biobanks currently operate across Europe. The term ‘biobank’ indicates a specific field of genetic study that has quietly developed without any significant critical reflection across European societies. Although scientists now routinely use this phrase, the wider public is still confused when the word ‘bank’ is being connected with the collection of their biological samples. There is a striking lack of knowledge of this field. In the recent Eurobarometer survey it was demonstrated that even in 2010 two-thirds of the respondents had never even heard about biobanks. The term gives the impression that a systematic collection of biological samples can constitute a ‘bank’ of considerable financial worth, where the biological samples, which are insignificant in isolation but are valuable as a collection, can be preserved, analysed and put to ‘profitable use’. By studying the practices of the numerous already existing biobanks, the authors address the following questions: to what extent does the term ‘biobank’ reflect the normative concept of using biological samples for the purposes of biomedical research? Furthermore, is it in harmony with the so far agreed legal–ethical consensus in Europe or does it deliberately pull science to the territory of a new, ambiguous commercial field? In other words, do biobanks constitute a medico-legal fiction or are they substantively different from other biomedical research protocols on human tissues?
- donation/procurement of organs/tissues
- genome mapping
- human genetics
- informed consent
- Oviedo Convention
- research on special populations
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Funding The publication is based on the research within the Tiss.Eu Project funded by the European Commission as part of the 7th Framework Programs.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.
- Law, ethics and medicine
- Research ethics
- The concise argument
Read the full text or download the PDF:
Other content recommended for you
- Biobanks for non-clinical purposes and the new law on forensic biobanks: does the Italian context protect the rights of minors?
- Public participation in genetic databases: crossing the boundaries between biobanks and forensic DNA databases through the principle of solidarity
- Collection, storage and use of blood samples for future research: views of Egyptian patients expressed in a cross-sectional survey
- Turning residual human biological materials into research collections: playing with consent
- Pregnancy cohorts and biobanking in sub-Saharan Africa: a systematic review
- Ethics in studies on children and environmental health
- Forensic DNA databases: genetic testing as a societal choice
- Obtaining informed consent for genomics research in Africa: analysis of H3Africa consent documents
- The retention of forensic DNA samples: a socio-ethical evaluation of current practices in the EU
- Impact of the European Convention on Human Rights on medical law